Back to top

NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with ...

NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases | NPCE Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

NeuroPace, Inc. (NPCE)